Adora Digital Health raises £940k Seed round for menopause support platform

Cambridge-based Adora Digital Health has secured an estimated £940k in Seed funding to scale its menopause support platform for employers. The company provides a digital health and wellbeing service designed to assist women through peri-menopause and menopause.

The platform targets the corporate benefits market, allowing employers to offer specialized health support to their workforce. Adora Digital Health provides personalized guidance, an AI companion, and direct online consultations with gynaecologists.

Founded in 2020, the company reported having six employees in its latest accounts for the year ended 28 June 2025. This latest capital injection follows a series of Seed allotments over the past three years. In January 2025, the company raised £151.9k, which followed a smaller £25.1k round in December 2023 and a £875.2k round in June 2023.

The current round (allotted in April and filed in May) brings the total estimated funding raised by the company across these documented Seed stages to approximately £1.99m. Adora Digital Health operates within the software development sector, focusing specifically on the intersection of femtech and employee wellness.

The platform provides expert-led support for women in the workplace experiencing menopausal symptoms. By providing direct access to medical professionals and AI-driven insights, the company addresses health challenges that can impact professional performance and retention. Adora Digital Health is headquartered in Cambridge and continues to develop its expert-led digital health tools for the B2B market.